 EMERYVILLE, Calif.--BUSINESS WIRE--NovaBay Pharmaceuticals, Inc. NYSE American: NBY reports financial results for the three and six months ended June 30, 2021 and provides a business update. Unit sales reached a new quarterly record as more people than ever before are using and benefitting from Avenova, said Justin Hall, President and CEO of NovaBay Pharmaceuticals. We also are reporting record revenue from the over-the-counter channel that increased sequentially from the first quarter 